Rising Prevalence of Cancer Drives the Market for Cancer Stem Cells, According to a New Trend Report Published by Global Industry Analysts, Inc.

GIA announces the release of a trend report on Cancer Stem Cells. Market for Cancer Stem Cells is projected to witness strong growth led by high prevalence of cancer worldwide, unmet medical needs in cancer treatment and diagnosis, strong investments in R&D, and supportive regulatory and reimbursement policies.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Cancer Stem Cells: A Trend Report

San Jose, California (PRWEB) January 20, 2014

Follow us on LinkedIn – Cancer Stem Cells (CSCs) are the cells within a tumor that possess the capability of self-renewal, driving tumorigenesis. Fuelled by the need for more effective treatment options and growing focus of the medical community to develop drugs and therapies that target tumor roots, research in the field of Cancer Stem Cells (CSCs) is attracting increased investments. Stem cells also known as progenitor cells, represent cells that are capable of regenerating malignant tumor cells and thus are responsible for the spread of cancer. As a key cause for tumor recurrence, metastasis, and resistance, cancer stem cells are therefore an important theme for R&D, especially as a drug target. The coming years are forecast to witness the development of novel drugs that target cancer stem cells (CSCs). Research efforts concerning CSCs would be focused on development of in vitro and in vivo methods for identification of CSCs and related biomarkers that would help understand the principles of tumour development and metastasis. Growing demand for effective and accurate cancer detection methodologies against the backdrop of rising cancer incidence is forecast to boost market prospects in the coming years.

The trend report titled “Cancer Stem Cells” announced by Global Industry Analysts Inc., is a focused research paper which provides cursory insights into the product, its applications, future prospects, and corporate initiatives of key companies worldwide. Also covered are companies such as Boston Biomedical Inc., Macrogenics, and Verastem, Inc.

For more details about this trend report, please visit http://www.strategyr.com/TrendReport.asp?code=141066

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###


Contact

Attachments